Statin use and pancreatic cancer risk in two prospective cohort studies

BACKGROUND: Statins, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are common lipid-lowering agents and may reduce the risk of several cancer types including pancreatic cancer. However, the association between statin use and pancreatic cancer risk has not been fully evaluated...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gastroenterol
Autori principali: Hamada, Tsuyoshi, Khalaf, Natalia, Yuan, Chen, Babic, Ana, Morales-Oyarvide, Vicente, Qian, Zhi Rong, Nowak, Jonathan A., Ng, Kimmie, Kraft, Peter, Rubinson, Douglas A., Stampfer, Meir J., Giovannucci, Edward L., Fuchs, Charles S., Ogino, Shuji, Wolpin, Brian M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7609961/
https://ncbi.nlm.nih.gov/pubmed/29362938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-018-1430-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi